Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Update on 2-DTech Ltd

4 Nov 2014 07:00

RNS Number : 0436W
Versarien PLC
04 November 2014
 

 

 

 

Press Release

4 November 2014

 

 

Versarien plc

("Versarien" or the "Group")

 

Update on 2-DTech Ltd

 

Versarien Plc (AIM:VRS), the advanced engineering materials group, is pleased to provide the following commercial update on 2-DTech Ltd ("2-DTech" or the "company"), the Group's graphene application and product development subsidiary which was acquired in May 2014.

 

Versarien also announces that 2-DTech will be hosting a site visit in Manchester for institutional investors, analysts and media on 19 November 2014. The site visit will enable the company to demonstrate the progress made since May in the commercialisation of graphene and will include a tour of the 2-DTech facility and presentations by leaders in this technology from 2-DTech and the University of Manchester.

 

In line with Versarien's strategy of supporting the road to product commercialisation through technology finance, 2-DTech has been awarded two separate grants from InnovateUK, formerly known as the Technology Strategy Board.

 

2-DTech will receive £80,000 for a collaborative project with Evodental, a leading dental implant company, to produce graphene-reinforced polymers for fixed dental prostheses.

 

• 2-DTech will receive £98,000 to explore the functionalisation of solid-state dye-sensitised solar cells which will be expedited in conjunction with Dyesol Ltd, the Australian solar clean tech company.

 

The InnovateUK grants supplement the existing £240,000 University of Manchester proof of concept grant for the commercialisation of a unique production process for which Versarien has now filed its first patent, jointly with the University of Ulster.

 

As a result of 2-DTech's progress and to strengthen the company's relationship with University of Manchester it has further strengthened the management team through two new senior appointments.

 

Dr. Aravind Vijayaraghaven, who is a lecturer in Nanomaterials at the University of Manchester, and is the public engagement coordinator for the National Graphene Institute, has joined 2-DTech as a Senior Consultant. The Board believes that Dr. Vijayaraghaven's reputation in the industry of nanomaterials and in the field of graphene will be of significant benefit to 2-DTech as it embarks on a number of planned collaboration projects.

 

2-DTech has also appointed Dr. Andrew Strudwick as a Research Scientist. Dr. Strudwick completed his PhD in the condensed matter physics department at the University of Leeds before working for BASF on commercialising graphene projects.

 

Neill Ricketts, Chief Executive Officer of Versarien, commented: "Since the acquisition in May, 2-DTech has made excellent progress with many of our key objectives being achieved well ahead of schedule whilst still keeping a strict control over costs. The two InnovateUK grants are testament to the hard work by 2-DTech and demonstrate our drive towards achieving early commercialisation of this very exciting discovery. We look forward to welcoming interested parties to the home of graphene where they will see how graphene is being developed and commercialised by 2-DTech through the combination of academic, scientific and commercial expertise."

 

For further information, please visit 2-DTech's new corporate website: http://2-dtech.com

 

- Ends -

 

For further information:

Versarien Plc

Neill Ricketts, Chief Executive Officer

Tel: +44 (0) 1594 888 622

Chris Leigh, Chief Financial Officer

www.versarien.com

 

Charles Stanley Securities

(Nominated Adviser and Broker)

Mark Taylor / Russell Cook

Tel: +44 (0) 20 7149 6000

 

Media Enquiries:

Abchurch Communications Limited

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7398 7719

jamie.hooper@abchurch-group.com

www.abchurch-group.com

 

Notes to Editors

 

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has two wholly owned subsidiaries, Versarien Technologies Ltd and Total Carbide Ltd, and holds an 85% stake in 2-DTech Ltd.

 

Versarien Technologies Limited ("VTL")

VTL owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals. Versarien primarily targets the thermal management industry exploiting the superb thermal properties exhibited by such materials. The company's lead product is VersarienCu, a micro-porous copper which on incorporation into liquid cooling systems, can improve efficiency by up to ten times. http://www.versarien.co.uk/

 

2-DTech Limited

On 1 May 2014, Versarien acquired 85% of the issued share capital of 2-DTech, a company closely aligned with The University of Manchester, the established home of graphene technology. 2-DTech specialises in the supply, characterisation and early stage development of graphene products. 2-DTech also works closely with industry and researchers to help turn scientific innovation into groundbreaking products. The acquisition will enable Versarien to apply its experience and expertise to commercialising graphene in the UK; demand for which is set to grow exponentially over the coming years. For further information about 2-DTech visit http://2-dtech.com/

 

Total Carbide Limited ("TC")

TC is one of the leading European manufacturers of sintered tungsten carbide, with a global customer base covering over forty different industries. It primarily manufactures arduous environment products for application in the oil and gas industry, along with multiple other industries. TC provides VTL with access to high volume manufacturing assets that have significantly expanded production of VersarienCu. http://www.totalcarbide.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSDLALVIIS
Date   Source Headline
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20205:18 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdvisory Panel
24th Sep 202012:07 pmRNSResult of AGM
23rd Sep 20207:00 amRNSPosting of Annual Report
1st Sep 20207:00 amRNSNotice of AGM
17th Aug 20207:00 amRNSUpdate re. Innovate UK Loan Agreement
11th Aug 20207:00 amRNSPreliminary Results
3rd Aug 20207:00 amRNSLaunch of Graphene Enhanced Protective Face Mask
1st Jul 20207:01 amRNS£5 million Innovate UK Loan Agreement
1st Jul 20207:00 amRNSCorporate Update and Notice of Results
19th Jun 20207:00 amRNSAppointment of Non-executive Chairman
12th Jun 20209:41 amRNSInvestor Communication
4th Jun 202012:02 pmRNSPrice Monitoring Extension
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:36 pmRNSPrice Monitoring Extension
28th Apr 202011:17 amRNS2-DTech awarded grant
23rd Apr 20207:00 amRNSRolls-Royce chooses to partner with GEIC & 2-DTech
15th Apr 20205:10 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSClarification: Sharing Agreement & China JV
2nd Apr 20203:32 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.